SignatureFD’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
SignatureFD's CTKB Position: Q3 2026 in Review
SignatureFD held its Cytek Biosciences (CTKB) position steady in Q3 2026 at 34 shares worth $203. The position accounts for ﹤0.01% of the portfolio, ranked #3471.
SignatureFD first reported a position in CTKB in Q3 2024 and has held it in 9 quarters since. The position peaked at $2.21K in Q4 2025. 150 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.
- SignatureFD held 34 shares of Cytek Biosciences worth $203 as of Q3 2026.
- SignatureFD left its Cytek Biosciences share count unchanged in Q3 2026.
- Cytek Biosciences made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3471 holding.
- SignatureFD first reported a position in Cytek Biosciences in Q3 2024 and has held it in 9 quarters since.
- SignatureFD's Cytek Biosciences position peaked at $2.21K in Q4 2025.
- 150 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.